The aim of the present review is to examine the cellular processes underlying the actions of these new, highly significant classes of peptide receptor agonists.
← all excerpts
Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data.
1
—
—